Key learning objectives:
- To discuss the comparative effects of switching from 10 to 5-dose vials of MR vaccine on vaccine coverage, wastage, dropouts, session size and frequency, storage and distribution and how this applies to other vaccines
- To provide first-hand country experiences in shifting to 5-dose vials
- To discuss in plenary the decision-making process in changing DPC
| Date & Time: | Thursday, 27 August 2020, 2020 09:00 AM Copenhagen time (CET) |
| Title: | Dose Per Container: The effects of switching to 5-dose vials on vaccine procurement |
| Presenters: | Wendy Prosser, Senior Technical Officer, Immunization Center, JSI, USA
Kongxay Phouphenghack,Head of Vaccine Preventable Disease, Mother and Child Health Centre, Ministry of Health, Vientiene Capital, Lao, PDR and Samphanh Khamsingsavath, Immunization Office, Programme Section, Vientiane, UNICEF |
| Plenary Key Respondents: | Amos Chweya, Regional Immunization Technical Officer, Immunization Center, JSI, Kenya
Bhrigu Kapuria, Health Specialist (Immunization) UNICEF India Lilia Velinova de Boever, Contracts Specialist, Supply Division, UNICEF Copenhagen |
| Moderators: | Andrea Papan, VPPN, Community of Practice Manager, UNICEF and Loic Sanchez, Supply Officer (Immunization), Supply Division, UNICEF |
To participate in this webinar, you must register here.
Additional Resources:
- The Decision Support Resource developed by the Dose Per Container Partnership is available as a guide for countries that are considering different vaccine presentations.
- K. Krudwig, B.Knittel, A. Karim, N. Kanagat, W.Prosser, G. Phiri, F. Mwansa, R. Steinglass, The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia, Vaccine, Volume 38, Issue 37, 2020, Pp. 5905-5913 https://www.sciencedirect.com/science/article/pii/S0264410X20309129
Also check out the cross-posted TechNet e-discussion presently taking place: https://www.technet-21.org/en/forums/discussions/evidence-to-action-it-s-time-for-5-dose-measles-vials-to-meet-immunization-program-needs-and-realities